Definitive Contract 75N91022C00039
Award Date
9/23/22
Potential Completion Date
9/22/23
Potential Value
$400K
Federal Agency
National Cancer Institute
Awardee
Standard Imaging Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Middleton, WI 53562, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI) has awarded a $1,222,441.00 Firm Fixed Price SBIR Phase II contract to Standard Imaging Inc., a small business manufacturer of specialized radiation measurement equipment and software. The contract, identified as 75N91024C00097, is for the development of a "Novel NIST Traceable Ionization Chamber for Flash Dosimetry" under SBIR Topic No. 434. This contract, set aside for small businesses, aims to advance the field of radiation measurement and therapy...
This $397,626 Firm Fixed Price contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Standard Imaging Inc., a small business manufacturer of radiation measurement equipment and software headquartered in Middleton, Wisconsin. The award is for the development of "A Novel Scintillation Detector System for Flash Radiation Therapy" under the NCI's Small Business Innovation Research (SBIR) program. This SBIR contract...
This is a $398,714 firm fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Irai Technologies, LLC, a minority-owned small business. The contract is for the development of a flash dosimetry system based on ionizing radiation acoustic imaging, under Solicitation PHS-2023-1 for the NIH and CDC SBIR program. The goal is to contribute toward NCI mission needs and SBIR program objectives by stimulating technological innovation and fostering participation from small,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
This is a $396,190 firm fixed price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Tetraimaging LLC, a small disadvantaged business, to develop ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract was awarded on September 16, 2022 and is set to complete by December 15, 2023. The original solicitation, PHS-2022-1, announced by the NIH and CDC, sought small business...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Radiopharmaceutical Imaging And Dosimetry, LLC (doing business as Radiopharmaceutical Imaging & Dosimetry LLC), a for-profit limited liability company. The $299,466.00 firm-fixed-price contract, which was set aside for small businesses, is for the development of user-friendly, platform-independent software to incorporate...
This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Woodtoga Holdings Company, a for-profit manufacturer, for the development of "Applicator-Compatible Electronic Brachytherapy Sources for Cancer Radiotherapy." The $399,779.00 firm fixed price contract runs through December 31, 2022 and is set aside for small businesses. This contract supports the SBIR program...
This is a $454,997 fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Ambay Immune Sensors And Controls, LLC, a woman-owned small business. The contract was awarded under the FY20 SBIR Phase I solicitation and is for the development of a "non-invasive, novel test to monitor biological response to radiotherapy" under Topic #400 - AMBAY RADI-SENSE. The contract...
This SBIR Phase I contract award of $399,870 to Oncospace Inc. will fund research and development of a software tool for standardizing radiotherapy treatment plans to support artificial intelligence validation. The contract responds to National Institutes of Health National Cancer Institute SBIR Topic 454 and will take place over one year in Baltimore, Maryland. It was awarded under the NIH/CDC SBIR solicitation seeking innovative solutions across over 125 topics related to cancer treatment,...